RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
 Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Sep 15, 2017 - 4:49:58 AM
Research Article
Latest Research Channel

subscribe to Latest Research newsletter
Latest Research

   EMAIL   |   PRINT

Hyperthyroidism linked to increased risk of hospitalization for heart and blood-vessel disease


Jun 23, 2012 - 4:00:00 AM

 

An overactive thyroid gland, or hyperthyroidism, may increase the risk of hospitalization for heart and blood-vessel disease even after surgery to remove the gland, according to a new study. The results will be presented Saturday at The Endocrine Society's 94th Annual Meeting in Houston.

Overactive thyroid gland has long-lasting effects on the patient's heart and vessels, said study principal investigator Saara Metso, M.D., Ph.D. assistant chief of endocrinology in the Department of Internal Medicine, Division of Endocrinology, at Tampere University Hospital in Tampere, Finland. Therefore, it is important to monitor the patient's heartbeat and blood pressure even years after the overactive thyroid gland has been cured.

The thyroid gland, located in the front of the neck, produces thyroid hormone, which helps regulate the process of turning food into energy. When the gland is overactive and produces excessive hormone, many bodily processes speed up. Symptoms include unexplained weight loss, rapid heart rate, increased appetite, profuse sweating, and feelings of anxiety.

Diagnosis of an overactive thyroid gland usually involves a simple blood test, and effective treatments are available. These include radioactive iodine, which destroys part of the thyroid gland; antithyroid medication to reduce thyroid-hormone synthesis; and surgery, or a thyroidectomy, to remove it.

Recently, however, questions were raised about the long-term health effects of treatment after some studies found that patients who had received radioactive iodine treatment or antithyroid medication had an increased risk of hospitalization for heart and blood-vessel disease. This risk persisted long after therapy ended, but it was unclear whether it was associated with the treatment itself or the prior overactive thyroid.

In findings implicating the disease rather than the treatment, the current study showed that patients who had undergone surgical thyroid removal also were at greater risk of being hospitalized for heart and blood-vessel disease. Overall, their risk was 17 percent greater compared to those without a history of overactive thyroid, and the increased risk persisted for as long as two decades after surgery.

Although overactive thyroid gland is usually easy to diagnose and treat, it may be injurious to the patient's heart and vessels, Metso said. It is probably the disease rather than the treatment that affects the patient's heart and vessels permanently.

Participants included 4,334 patients diagnosed with overactive thyroid who underwent thyroidectomy in Finland between 1986 and 2007, and 12,991 age- and gender-matched controls. They were 86 percent female, their average age was 46 years, and all were white. Average follow-up was 10.5 years.

Investigators obtained hospitalization information from Finland's national Hospital Discharge Registry for the study. They received funding from Research Funding of the Pirkanmaa Hospital District, Finland.

Hyperthyroidism affects approximately 1 percent of the U.S. population. The most common cause is an autoimmune disorder called Grave's disease.


Related Latest Research News


Subscribe to Latest Research Newsletter

Enter your email address:


 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

Online ACLS Certification

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)